Indeed, epidemiological evidence suggests that aP-elicited immunity confers limited protection from infection of the nasopharynx by B. pertussis and enables elevated rates of more-or-less asymptomatic and largely undiagnosed pertussis transmission by highly aP-vaccinated individuals (4, 6, 64, 65). Here, DHCR7-DT is linked to pertussis.